Specific drugs for specific ventricular arrhythmias: an evaluation of current therapy and the role of propafenone.
Drug management of ventricular arrhythmias follows few scientific principles. Specific therapy for specific arrhythmias must be a goal for the future. Already a few important arrhythmia subtypes demanding specific therapy have been identified. As new drugs become available, they may offer particular effects against identifiable clinical arrhythmias.